Literature DB >> 26296053

DOME-SHAPED MACULA WITH THICKENED CHOROID IN AN EMMETROPIC PATIENT.

Napang Kedkovid1, Armin R Afshar, Bertil E Damato, Jay M Stewart.   

Abstract

PURPOSE: To report a rare case of bilateral dome-shaped macula in an emmetropic patient.
METHOD: Clinical case report and literature review.
RESULTS: A 42-year-old woman presented with a history of blurred vision in the right eye. Visual acuity was 20/30 in the right eye and 20/20 in the left eye. Intraocular pressure and anterior segment were unremarkable. Fundus examination revealed dull macular reflex and subretinal fluid nasal to the fovea in the right eye and a hyperpigmented area inferotemporal to the fovea in the left eye. Spectral domain optical coherence tomography showed subretinal fluid under the fovea in the right eye and elevation of the macula with increased choroidal thickness in both eyes. Fluorescein angiography revealed abnormal hyperfluorescence without any leakage in both eyes. B-scan ultrasound showed irregular globe contour with high internal reflectivity and dome-shaped lesions at the posterior pole in both eyes. Axial length was 24.6 mm in the right eye and 25.6 mm in the left eye.
CONCLUSION: Although most commonly reported in myopic eyes, dome-shaped macula can occur in an emmetropic patient and can be associated with subretinal fluid.

Entities:  

Mesh:

Year:  2015        PMID: 26296053     DOI: 10.1097/ICB.0000000000000198

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  2 in total

1.  CORRELATION BETWEEN POSTERIOR STAPHYLOMA AND DOME-SHAPED MACULA IN HIGH MYOPIC EYES.

Authors:  Fangfang Dai; Shuyin Li; Yanting Wang; Shuangshuang Li; Jinfeng Han; Mengdi Li; Zhong Zhang; Xuemin Jin; Shewei Dou
Journal:  Retina       Date:  2020-11       Impact factor: 3.975

2.  Quantification and Predictors of OCT-Based Macular Curvature and Dome-Shaped Configuration: Results From the UK Biobank.

Authors:  Philipp L Müller; Yuka Kihara; Abraham Olvera-Barrios; Alasdair N Warwick; Catherine Egan; Katie M Williams; Aaron Y Lee; Adnan Tufail
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-08-02       Impact factor: 4.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.